Andrew Fedder

General Counsel at Antares Therapeutics.

Earliest Form D on file: Mar 2025

2 filings at 1 company

Antares Therapeutics

Biotech, Boston MA

General Counsel · signer

Biotech, Boston MA

Signed
Named
Size is amount sold, up to $30M

Filings

2

May 15, 2025
Equity, signed · Form D
$30M
of $136.65M
May 15, 2025
Equity
Signed as General Counsel
$30M
$136.65M
Form D
Mar 12, 2025
Debt, option to acquire, security to be acquired, signed · Form D
$40M
of $40M
Mar 12, 2025
Debt, option to acquire, security to be acquired
Signed as General Counsel
$40M
$40M
Form D

Network

At Antares Therapeutics

7 people

Adam Friedman
Together on 2 filings
Executive Officer, Director
Brian Piper
Together on 2 filings
Executive Officer, Director
Jean-Francois Formela
Together on 1 filing
Director
Jeffrey Albers
Together on 1 filing
Director
Keith Flaherty
Together on 1 filing
Director
Menelas Pangalos
Together on 1 filing
Director

1 more at Antares Therapeutics